Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Morrison Briggs

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorAug 09, 2023Option Exercise$8.7752,855463,53870,691Aug 10, 2023, 06:50 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorAug 09, 2023Sale$18.2752,855965,40217,836Aug 10, 2023, 06:50 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJul 10, 2023Option Exercise$8.7752,855463,53870,691Jul 11, 2023, 09:23 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJul 10, 2023Sale$20.4052,8551,078,06817,836Jul 11, 2023, 09:23 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJun 09, 2023Sale$21.1852,8551,119,42146,109Jun 09, 2023, 05:32 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJun 09, 2023Option Exercise$7.6652,855404,78770,691Jun 09, 2023, 05:32 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorMay 09, 2023Option Exercise$6.3852,855337,21570,691May 10, 2023, 04:11 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorMay 09, 2023Sale$21.4152,8551,131,47817,836May 10, 2023, 04:11 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorApr 10, 2023Sale$19.5352,8551,032,23717,836Apr 12, 2023, 04:03 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorApr 10, 2023Option Exercise$6.3852,855337,21570,691Apr 12, 2023, 04:03 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DMar 13, 2023Option Exercise$6.3852,854337,20970,690Mar 14, 2023, 04:42 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DMar 13, 2023Sale$22.5352,8541,190,67417,836Mar 14, 2023, 04:42 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DFeb 06, 2023Option Exercise$6.3852,854337,20970,690Feb 08, 2023, 04:49 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DFeb 06, 2023Sale$26.8352,8541,417,90917,836Feb 08, 2023, 04:49 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 19, 2022Option Exercise$10.90114,3391,246,295132,175Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 19, 2022Sale$23.03114,3392,633,04417,836Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 20, 2022Option Exercise$10.9059,649650,17477,485Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 20, 2022Sale$23.2559,6491,387,01217,836Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 16, 2022Option Exercise$8.77125,0001,096,22689,802Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 16, 2022Sale$23.22125,0002,902,43717,836Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 14, 2022Option Exercise$7.2087,645631,044105,481Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 14, 2022Sale$23.8087,6452,085,85517,836Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 15, 2022Option Exercise$7.2066,775480,78084,611Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 15, 2022Sale$24.2066,7751,616,03517,836Sep 16, 2022, 05:34 PM
ARVNARVINAS, INC.Morrison BriggsDirectorApr 14, 2022Sale$66.4420,9601,392,61637,834Apr 18, 2022, 09:00 PM
ARVNARVINAS, INC.Morrison BriggsDirectorApr 14, 2022Option Exercise$16.0016,188259,00840,936Apr 18, 2022, 09:00 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 01, 2022Option Exercise$7.2070,545507,92488,381Apr 13, 2022, 04:09 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 04, 2022Option Exercise$7.203,12822,52220,964Apr 13, 2022, 04:09 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 04, 2022Option Exercise$10.903,12834,09520,964Apr 05, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 04, 2022Sale$18.293,12857,22017,836Apr 05, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 01, 2022Option Exercise$10.9070,545768,94088,381Apr 05, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 01, 2022Sale$17.45101,0451,763,51542,336Apr 05, 2022, 04:05 PM
ARVNARVINAS, INC.Morrison BriggsDirectorJan 14, 2022Option Exercise$16.0016,188259,00845,708Jan 19, 2022, 09:00 PM
ARVNARVINAS, INC.Morrison BriggsDirectorJan 14, 2022Sale$65.5520,9601,374,02135,789Jan 19, 2022, 09:00 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerDec 17, 2021Option Exercise$10.9035,156383,20083,492Dec 20, 2021, 06:44 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerDec 17, 2021Sale$20.0035,156703,12048,336Dec 20, 2021, 06:44 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 17, 2021Option Exercise$7.2070,262505,886118,598Sep 21, 2021, 04:35 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 17, 2021Sale$20.0770,2621,410,01848,336Sep 21, 2021, 04:35 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 20, 2021Option Exercise$7.205036048,386Sep 21, 2021, 04:35 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 20, 2021Sale$20.00501,00048,336Sep 21, 2021, 04:35 PM
CDAKCodiak BioSciences, Inc.Morrison BriggsDirectorFeb 17, 2021Buy$21.004,76199,9814,761Feb 17, 2021, 06:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerFeb 08, 2021Option Exercise$7.2035,156253,12383,492Feb 10, 2021, 04:23 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerFeb 08, 2021Sale$20.5535,156722,40348,336Feb 10, 2021, 04:23 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerJan 31, 2021Option Exercise$12.001,77121,25248,336Feb 05, 2021, 04:21 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 10, 2020Option Exercise$7.2017,466125,75564,031Nov 12, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 10, 2020Sale$20.0617,466350,31246,565Nov 12, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 09, 2020Option Exercise$7.2062,938453,154109,503Nov 12, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 09, 2020Sale$20.0462,9381,261,26546,565Nov 12, 2020, 05:55 PM
RPTXRepare Therapeutics Inc.Morrison BriggsDirectorJun 23, 2020Buy$20.004,80096,0004,800Jun 25, 2020, 05:57 PM
ARVNARVINAS, INC.Morrison BriggsDirectorMar 24, 2020Buy$38.182,50095,45029,520Mar 25, 2020, 04:45 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerFeb 04, 2020Buy$8.0012,500100,00043,900Feb 05, 2020, 04:07 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerOct 10, 2019Buy$5.4011,00059,40031,400Oct 11, 2019, 06:33 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerMay 09, 2019Buy$7.5513,20099,72613,200May 13, 2019, 04:11 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerMay 13, 2019Buy$7.297,20052,51720,400May 13, 2019, 04:11 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe